About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Merck Paid "Nurses" to Comb Medical Records for Potential Vioxx Patients

By Jim Edwards | May 18, 2009

Merck paid “nurses” to comb medical records for potential Vioxx patients, an Australian court has heard. The nurses went through patient records with doctors’ permission, looking for 100 patients at each doc who weren’t on Vioxx but could be, according to The Australian.

The paper reported that Merck sought to persuade pharmacists to recommend Vioxx to patients who were on paracetemol by giving them free copies of the Merck manual.

The trial also revealed an end of year skit put on by Merck drug sales reps who made fun of the Journal of the American Medical Association, which had published an article about cardiovascular concerns with Vioxx. The skit renamed it the “Journal of the American Mullet Association,” and featured a picture of a man with the business-in-front, party-in-back do.

News of the skit is deliciously ironic because of previous revelations in the trial that Merck created a fake medical journal, the “Australasian Journal of Bone and Joint Medicine” (click here for a copy), in which to promote its products.

Separately and not entirely seriously, Merck is not the only drug company that created a fake medical journal to promote its products. Phoni Pharmaceuticals paid medical publisher Elsleazier to print the “Australian Journal of Boneheads and Joints Medicine,” Pharma Giles writes:

The spokesperson added that Elsleazier had no plans to look further into the matter.  “The high prices of subscriptions to our journals are a guarantee of their quality,” he said.  “After all, everyone recognises the quality of Australian scientific publications, in the same way that American diplomacy journals or Nigerian accountancy and banking magazines are regarded … “

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Merck - Vioxx: Nurse Clouseau is on your trail

    PharmaGossip - 266 days 6 hours 17 minutes ago

    "Bone Care Nurse"! Too easy!!!!! AUSTRALIAN marketing staff from pharmaceutical giant Merck & Co paid specialist nurses half-a-

  • Aussie nurses paid to find Vioxx patients

    FiercePharma - 266 days 8 hours 41 minutes ago

    Australia has often been compared to the American Wild West--you know, rebellious, independent, a bit lawless--but even that doesn't account for the accusations flying in Australian court these days.  Merck is fighting a class action suit over its long-withdrawn painkiller Vioxx; the case is now being tried in Australian Federal Court. The...

  • Obama backs investors' rights in Merck case

    FiercePharma - 105 days 9 hours 20 minutes ago

    Investors suing Merck over Vioxx got a boost from the White House yesterday. In an amicus curiae brief filed with the Supreme Court, the Obama administration backed the investors' right to sue the drugmaker. You'll remember that Merck contended the shareholders should have sued earlier; information about Vioxx risks had been public for awhile by...

  • Merck To Supremes: Investors Should Have Sued Us Sooner

    WSJ Health Blog - 70 days 9 hours 8 minutes ago

    The Supreme Court heard oral arguments over securities lawsuits that allege Merck downplayed the safety risks of Vioxx

  • Merck -- Vioxx: it must be true, I read it in The Australasian Journal of Bone and Joint Medicine

    PharmaGossip - 307 days 7 hours 4 minutes ago

    SCIENTISTS were allegedly recruited by a pharmaceutical giant to put their names on research done by the drug company to promote the safety of its anti-arthritis drug Vioxx. The Federal Court has heard that Merck & Co "prepared and gathered" doctors and academics to write the company's own research on Vioxx, which was then published in...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement